Travis Steed analyst BAML

Currently out of the existing stock ratings of Travis Steed, 50 are a HOLD (29.94%), 105 are a BUY (62.87%), 12 are a SELL (7.19%).

Travis Steed

Work Performance Price Targets & Ratings Chart

Analyst Travis Steed, currently employed at BAML, has had 62.32% of price targets met with an average potential upside of 19.04%, reached in 244 days on average.

Travis Steed has documented 333 price targets and ratings displayed on 33 stocks. The coverage is on Healthcare, Financial Services, Communication Services sectors.

Most recent stock forecast was given on AXGN, Axogen at 12-Oct-2026.

Wall Street Analyst Travis Steed

Analyst best performing recommendations are on LUNG (PULMONX CORP).
The best stock recommendation documented was for LUNG (PULMONX CORP) on 1/3/2023. The price target of $8 was fulfilled within 1 day with a profit of $0.51 (6.81%), with a performance score of 68.09.

Average potential price target upside

ABT Abbott Laboratories AXNX Axonics Modulation Technologies DXCM DexCom INMD InMode Ltd ZBH Zimmer Biomet Holdings BAX Baxter International BDX Becton Dickinson and Company BSX Boston Scientific Corp EW Edwards Lifesciences Corp ISRG Intuitive Surgical MDT Medtronic PLC PODD Insulet SYK Stryker TNDM Tandem Diabetes Care CNMD CONMED LUNG Pulmonx Corp SWAV Shockwave Medical WMGI Wright Medical Group N.V INSP Inspire Medical Systems NARI Inari Medical SILK Silk Road Medical AXGN Axogen OM Outset Medical SOLV Solventum Corp. IART Integra LifeSciences Holdings EMBC Embecta Corp PEN Penumbra AX Axos Financial CSII Cardiovascular Systems WMG Warner Music Group MASI Masimo BBNX MMED

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 16-Jun-2025

$124

$21 (20.39%)

$106

2 days ago
(19-Nov-2026)

Buy Since 29-Jun-2017

$120

$17 (16.50%)

$112

29 days ago
(23-Oct-2026)

25/35 (71.43%)

$16.3 (15.72%)

418

Buy Since 06-Jun-2019

$122

$19 (18.45%)

$112

30 days ago
(22-Oct-2026)

25/33 (75.76%)

$19.49 (19.01%)

420

Buy Since 01-Jul-2026

$123

$20 (19.42%)

$121

30 days ago
(22-Oct-2026)

0/2 (0%)

$20.49 (19.99%)

Buy Since 23-Oct-2018

$118

$15 (14.56%)

$120

30 days ago
(22-Oct-2026)

10/15 (66.67%)

$15.49 (15.11%)

354

Show more analysts

Please expand the browser size to see the chart

Which stock is Travis Steed most bullish on?

Potential upside of $115.95 has been obtained for ISRG (INTUITIVE SURGICAL)

Which stock is Travis Steed most reserved on?

Potential downside of -$12.78 has been obtained for BDX (BECTON DICKINSON AND COMPANY)

What Year was the first public recommendation made by Travis Steed?

On 2015
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?